Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/62367
Title: Impact of Australia's 60-Day Dispensing Policy on Medicine Use: An Interrupted Time Series of the Stage 1 Roll-out.
Authors: Janetzki J.;Pratt N.;Dalli L.;Cataldo-Miranda P.;Pearson S.-A.;Talic S.;Ellett L.K.
Monash Health Department(s): Monash University - School of Clinical Sciences at Monash Health
Cardiology (MonashHeart)
Monash University - School of Public Health and Preventative Medicine
Institution: (Janetzki, Pratt, Ellett) Quality Use of Medicines and Pharmacy Research Centre, College of Health, Adelaide University, Adelaide, SA, Australia
(Dalli) Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia
(Dalli) Victorian Heart Institute, Monash University, Clayton, VIC, Australia
(Cataldo-Miranda, Talic) PharmacoEpidemiology Research Group (PERG), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
(Pearson) Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, UNSW, Australia
Issue Date: 19-Oct-2026
Copyright year: 2026
Publisher: medRxiv
Place of publication: United States
Publication information: medRxiv. (no pagination), 2026. Date of Publication: 09 Sep 2026.
Journal: medRxiv
Abstract: Objective: To evaluate the real-world impact of Stage 1 of Australia's 60-day dispensing policy on medicine utilisation and contextualise changes in dispensing with medicine shortages. Method(s): We conducted an interrupted time series analysis of aggregated national monthly dispensing data from the Pharmaceutical Benefits Scheme and Repatriation Pharmaceutical Benefits Scheme for the 247 medicines included in Stage 1 of the 60-day dispensing policy. Data from January 2020 to October 2025 were analysed, with September 2023 defined as policy implementation. Linear regression assessed changes in monthly dispensing trends before and after implementation, accounting for autocorrelation and seasonal variation. A relative change of at least +/-5% in the post-intervention dispensing slope compared with the pre-intervention slope was prespecified as a potentially clinically meaningful change. Therapeutic Goods Administration shortage reports were used to contextualise observed changes. Result(s): Of 247 medicines, 131 (53%) had increasing and 116 (47%) had decreasing post-intervention dispensing trends; of which 86 (66%) and 71 (61%), were statistically significant, respectively. However, only 8 medicines (3%) demonstrated at least +/-5% relative change in dispensing slope, six of which had reported shortages. Medicine-specific changes coincided with shortages, product deletions and therapeutic substitution, complicated attribution of changes to the 60-day dispensing policy. Conclusion(s): Stage 1 of Australia's 60-day dispensing policy was not associated with widespread changes in dispensing for most included medicines. Limited changes were plausibly influenced by concurrent shortages and other supply-related events. These findings provide reassurance that extended dispensing did not result in major increases in medicine utilisation at the population level, although continued monitoring is warranted as policy uptake expands.Copyright © 2026, Posted by openRxiv
DOI: http://monash.idm.oclc.org/login?url=10.64898/2026.09.09.26362679
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/62367
Type: Preprint
Subjects: Australia
autocorrelation
drug shortage
drug substitution
drug use
drug utilization
linear regression analysis
pharmacoeconomics
reassurance
seasonal variation
special situation for pharmacovigilance
time series analysis
Appears in Collections:Articles

Show full item record

Page view(s)

50
checked on Nov 12, 2026

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.